This inventor holds 1 USPTO granted patent and 3 published patent applications and 1 EPO patent. Top assignee: Boehringer Ingelheim International Gmbh. Active years: 2025.
Company Filing History:
Years Active: 2025
Title: The Innovations of Thorsten Lehmann
Introduction
Thorsten Lehmann is a notable inventor based in Biberach, Germany. He has made significant contributions to the field of pharmaceuticals, particularly through his innovative research and development efforts. His work focuses on compounds that have therapeutic applications, showcasing his commitment to advancing medical science.
Latest Patents
Thorsten Lehmann holds 1 patent for his invention titled "Substituted pyrazine-carboxamide derivatives." This patent relates to compounds that are designed for the treatment and/or prevention of conditions associated with the function of metabotropic glutamate receptor subtype 4 (mGluR4). The invention includes a detailed process for manufacturing these compounds, as well as pharmaceutical compositions that contain them.
Career Highlights
Lehmann is currently employed at Boehringer Ingelheim International GmbH, a leading global pharmaceutical company. His role involves extensive research and development, contributing to the creation of innovative therapeutic solutions. His expertise in medicinal chemistry has positioned him as a valuable asset within the organization.
Collaborations
Throughout his career, Thorsten has collaborated with esteemed colleagues, including Roland Pfau and Georg Dahmann. These partnerships have fostered a collaborative environment that enhances the research and development process, leading to groundbreaking advancements in pharmaceutical science.
Conclusion
Thorsten Lehmann's contributions to the field of pharmaceuticals through his innovative patents and collaborative efforts highlight his dedication to improving healthcare. His work continues to influence the development of new therapies, making a significant impact on the medical community.